title: Targeting Low Disease Activity in Elderly-Onset Rheumatoid Arthritis: Current and Future Roles of Biological Disease-Modifying Antirheumatic Drugs.
abstract: Elderly rheumatoid arthritis (RA) is classified into two clinical subsets, elderly-onset RA (EORA) and younger-onset elderly RA. With the improvement of life expectancy in the general population and advent of the super-aging society, the number of patients with EORA is anticipated to increase. Both large and small joints are affected initially at onset, and individuals with early EORA have higher scores of disease activity and levels of acute-phase reactants than those with early younger-onset RA. EORA is a progressive disease similar to younger-onset RA. Tumor necrosis factor (TNF) inhibitors are equally or slightly less effective in elderly patients than in younger patients with RA, and disease duration may have a greater impact on disease outcomes than age. Evidence of non-TNF biological disease-modifying antirheumatic drug use in EORA is limited. TNF inhibitors may not increase the risk for infection in elderly patients any more than methotrexate; however, increasing age is an independent and strong risk factor for serious infections in patients with RA. Treatment choice in patients with EORA is strongly influenced by comorbidities, especially cardiovascular disease, chronic lung disease, and frailty. To prevent progression to irreversible geriatric syndromes, non-frail patients with EORA, who are aging successfully should undergo intensive treatment using the treat-to-target strategy, and pre-frail and frail patients with EORA should be treated with the aim of returning to a non-frail or pre-frail stage, respectively. An appropriate treatment strategy for EORA and younger-onset elderly RA should be developed in the next decade using a multi-disciplinary approach.
authors.affiliation: Department of Medicine and Rheumatology, Tokyo Metropolitan Geriatric Hospital, 35-2 Sakae-cho, Itabashi-ku, Tokyo, 173-0015, Japan.
authors.forename: Takahiko
authors.initials: T
authors.lastname: Sugihara
authors.affiliation: Department of Epidemiology and Pharmacoepidemiology, Institute of Rheumatology, Tokyo Women's Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo, 162-0054, Japan. harigai.masayoshi@twmu.ac.jp.
authors.forename: Masayoshi
authors.initials: M
authors.lastname: Harigai
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D018450:Disease Progression; D015577:Geriatric Assessment; D006801:Humans; D000067562:Late Onset Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D054539:Medication Therapy Management; D062072:Patient Acuity; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha
references.citation: Rheumatology (Oxford). 2014 Apr;53(4):671-7
references.pmid: 24352338
references.citation: Rheumatology (Oxford). 2015 May;54(5):798-807
references.pmid: 25296748
references.citation: Ann Rheum Dis. 2013 Nov;72(11):1819-25
references.pmid: 23155222
references.citation: Am J Kidney Dis. 2004 May;43(5):861-7
references.pmid: 15112177
references.citation: Scand J Rheumatol. 2010;39(5):360-7
references.pmid: 20476859
references.citation: Musculoskeletal Care. 2007 Dec;5(4):175-90
references.pmid: 17623274
references.citation: Ann Rheum Dis. 2016 Jan;75(1):3-15
references.pmid: 25969430
references.citation: J Rheumatol. 2014 Jan;41(1):15-23
references.pmid: 24187110
references.citation: J Rheumatol. 2006 Nov;33(11):2132-8
references.pmid: 17014003
references.citation: Arthritis Rheum. 2011 Mar;63(3):633-9
references.pmid: 21360492
references.citation: Arthritis Care Res (Hoboken). 2013 May;65(5):737-44
references.pmid: 23139011
references.citation: Ann Rheum Dis. 2001 Nov;60(11):1021-4
references.pmid: 11602472
references.citation: Ann Rheum Dis. 2004 Jul;63(7):804-8
references.pmid: 15194575
references.citation: J Am Geriatr Soc. 2011 Nov;59(11):2129-38
references.pmid: 22091630
references.citation: Arthritis Rheum. 2010 Mar;62(3):674-82
references.pmid: 20187135
references.citation: Arthritis Res Ther. 2012 Nov 23;14(6):R254
references.pmid: 23176083
references.citation: Ann Intern Med. 2007 Mar 20;146(6):406-15
references.pmid: 17371885
references.citation: Mod Rheumatol. 2014 May;24(3):390-8
references.pmid: 24252049
references.citation: Arthritis Rheum. 2011 Oct;63(10):2865-72
references.pmid: 21647867
references.citation: Ann Rheum Dis. 2016 Jan;75(1):16-22
references.pmid: 25990290
references.citation: Ann Rheum Dis. 2008 Feb;67(2):189-94
references.pmid: 17644554
references.citation: Am J Geriatr Pharmacother. 2007 Dec;5(4):345-51
references.pmid: 18179993
references.citation: Ann Rheum Dis. 2007 Mar;66(3):308-12
references.pmid: 16984941
references.citation: J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M158-66
references.pmid: 11253157
references.citation: Arthritis Care Res (Hoboken). 2015 May;67(5):624-32
references.pmid: 25370912
references.citation: Joint Bone Spine. 2001 Oct;68(5):403-9
references.pmid: 11707006
references.citation: J Rheumatol. 2013 Dec;40(12):1958-66
references.pmid: 23950188
references.citation: Rheumatology (Oxford). 2014 Feb;53(2):293-9
references.pmid: 24158755
references.citation: Arthritis Rheum. 2012 Sep;64(9):2847-55
references.pmid: 22576809
references.citation: Rheumatology (Oxford). 2009 Oct;48(10):1261-4
references.pmid: 19651885
references.citation: Ann Rheum Dis. 2004 Aug;63(8):910-6
references.pmid: 15249317
references.citation: Ann Rheum Dis. 2014 Mar;73(3):529-35
references.pmid: 24401994
references.citation: J Gerontol A Biol Sci Med Sci. 2015 Mar;70(3):339-44
references.pmid: 25063080
references.citation: Int J Immunopathol Pharmacol. 2009 Apr-Jun;22(2):415-26
references.pmid: 19505394
references.citation: Rheumatology (Oxford). 2007 Feb;46(2):350-7
references.pmid: 16908509
references.citation: Arthritis Rheum. 2002 Sep;46(9):2287-93
references.pmid: 12355475
references.citation: Ann Rheum Dis. 2007 Sep;66(9):1132-6
references.pmid: 17251223
references.citation: Arthritis Rheum. 2005 Feb;52(2):402-11
references.pmid: 15693010
references.citation: Ann Rheum Dis. 2015 Jun;74(6):1037-44
references.pmid: 24550168
references.citation: Arthritis Rheum. 2004 Jul;50(7):2082-93
references.pmid: 15248205
references.citation: Joint Bone Spine. 2015 Jan;82(1):25-30
references.pmid: 25241333
references.citation: J Am Geriatr Soc. 2012 Apr;60(4):616-31
references.pmid: 22376048
references.citation: Rheumatology (Oxford). 2004 May;43(5):655-7
references.pmid: 14970400
references.citation: Arthritis Rheum. 2007 Sep;56(9):2905-12
references.pmid: 17763428
references.citation: Clin Exp Rheumatol. 2017 May-Jun;35(3):390-400
references.pmid: 28079500
references.citation: Ann Rheum Dis. 2010 Jun;69(6):1086-91
references.pmid: 20444754
references.citation: Arthritis Rheum. 2007 Jun;56(6):1754-64
references.pmid: 17530704
references.citation: Ann Rheum Dis. 2010 Jul;69(7):1333-7
references.pmid: 20498212
references.citation: Ann Rheum Dis. 2007 Nov;66(11):1443-9
references.pmid: 17519278
references.citation: Ann Rheum Dis. 2015 Jun;74(6):1065-71
references.pmid: 24608404
references.citation: Arthritis Rheum. 2002 Mar;46(3):625-31
references.pmid: 11920397
references.citation: J Rheumatol. 2011 Jul;38(7):1258-64
references.pmid: 21498482
references.citation: Semin Arthritis Rheum. 2012 Aug;42(1):23-31
references.pmid: 22465003
references.citation: N Engl J Med. 2007 Nov 1;357(18):1874-6
references.pmid: 17978303
references.citation: Rheumatology (Oxford). 2009 Dec;48(12):1575-80
references.pmid: 19812228
references.citation: Ann Rheum Dis. 2006 Sep;65(9):1226-9
references.pmid: 16414968
references.citation: Drugs Aging. 2007;24(3):239-54
references.pmid: 17362051
references.citation: Rheumatology (Oxford). 2011 Jan;50(1):124-31
references.pmid: 20675706
references.citation: Arthritis Rheum. 2002 Sep;46(9):2294-300
references.pmid: 12355476
references.citation: Rheumatology (Oxford). 2006 Dec;45(12):1558-65
references.pmid: 16705046
references.citation: Arthritis Rheum. 2007 May 15;57(4):679-85
references.pmid: 17471545
references.citation: Clin Rev Allergy Immunol. 2010 Apr;38(2-3):90-6
references.pmid: 19548124
references.citation: J Rheumatol. 2006 Feb;33(2):234-43
references.pmid: 16465653
references.citation: Arthritis Rheum. 2010 Jun;62(6):1576-82
references.pmid: 20191579
references.citation: Arthritis Rheum. 2006 Mar;54(3):702-10
references.pmid: 16508926
references.citation: Arthritis Care Res (Hoboken). 2012 Aug;64(8):1125-34
references.pmid: 22422487
references.citation: Ann Rheum Dis. 2006 Mar;65(3):379-84
references.pmid: 16150792
references.citation: J Rheumatol. 2002 Sep;29(9):1851-7
references.pmid: 12233878
references.citation: Nat Rev Rheumatol. 2014 Apr;10(4):252-6
references.pmid: 24418765
references.citation: Rheumatology (Oxford). 2009 Aug;48(8):906-10
references.pmid: 19478038
references.citation: Ann Rheum Dis. 2010 Apr;69(4):631-7
references.pmid: 20215140
references.citation: Rheumatology (Oxford). 1999 Mar;38(3):228-34
references.pmid: 10325661
references.citation: J Rheumatol. 1991 Sep;18(9):1285-9
references.pmid: 1757926
references.citation: Rheumatology (Oxford). 2013 Jan;52(1):45-52
references.pmid: 22986289
references.citation: Arthritis Rheum. 1985 Sep;28(9):987-94
references.pmid: 4038365
references.citation: Rheumatology (Oxford). 2013 Dec;52(12):2136-48
references.pmid: 24003249
references.citation: Ann Rheum Dis. 2014 Apr;73(4):748-51
references.pmid: 23904472
references.citation: Arthritis Rheum. 2006 Oct;54(10):3119-25
references.pmid: 17009230
references.citation: J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
references.pmid: 11253156
references.citation: Mod Rheumatol. 2012 Aug;22(4):498-508
references.pmid: 21993918
references.citation: Geriatr Gerontol Int. 2011 Oct;11(4):438-44
references.pmid: 21545384
references.citation: Rheumatology (Oxford). 2005 May;44(5):695-6
references.pmid: 15705631
references.citation: Arthritis Rheum. 2000 Aug;43(8):1831-5
references.pmid: 10943873
references.citation: Rheumatology (Oxford). 2011 Nov;50(11):1999-2004
references.pmid: 21856725
references.citation: Ann Rheum Dis. 2010 Sep;69(9):1580-8
references.pmid: 20699241
references.citation: Ann Rheum Dis. 2012 Jul;71(7):1128-33
references.pmid: 22241902
references.citation: Ann Rheum Dis. 2014 Mar;73(3):492-509
references.pmid: 24161836
references.citation: Arthritis Rheum. 2005 Mar;52(3):722-32
references.pmid: 15751097
references.citation: Arthritis Rheum. 2007 Aug 15;57(6):928-34
references.pmid: 17665462
references.citation: Ann Rheum Dis. 2009 Sep;68(9):1470-3
references.pmid: 19015210
references.citation: Ann Rheum Dis. 2011 Dec;70(12):2148-51
references.pmid: 21852254
references.citation: Arthritis Care Res (Hoboken). 2013 Mar;65(3):353-61
references.pmid: 22833532
references.citation: J Rheumatol. 2003 Apr;30(4):691-6
references.pmid: 12672185
references.citation: Mod Rheumatol. 2011 Aug;21(4):343-51
references.pmid: 21264488
references.citation: Arthritis Rheum. 2010 Jan;62(1):22-32
references.pmid: 20039405
references.citation: Arthritis Rheum. 2010 Jun;62(6):1583-91
references.pmid: 20155830
references.citation: BMC Geriatr. 2015 Jul 09;15:77
references.pmid: 26155837
references.citation: JAMA. 2015 Jul 14;314(2):170-80
references.pmid: 26172896
references.citation: Rheumatology (Oxford). 2014 Jan;53(1):76-84
references.pmid: 24056521